http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111377979-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79237ae0f38313f246548c64aa51a99
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F17-02
filingDate 2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0a1c4a0c0f5e70d5d060ad6d8de4022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413742244772103d4b275d2e343c08af
publicationDate 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111377979-A
titleOfInvention A kind of synthetic method of intermediate bis(carboxycyclopentadiene) iron complex
abstract The invention discloses a method for synthesizing bis(carboxycyclopentadiene) ferrous compound, comprising 1,1'-diacetylferrocene, cuprous chloride, N-methylimidazole, toluene, butane, bromine 1-pentyl-methylimidazole and concentrated sulfuric acid are the main raw materials; the synthesis process of the present invention adopts self - made [C 5 mim]HSO ionic liquid as a reaction solvent, and forms a uniformly dispersed oxidation system catalyzed by CuCl and the ionic liquid to catalyze the preparation of bi( Carboxycyclopentadiene) ferric oxide can realize the catalytic oxidation of diacetylferrocene in a relatively short time, and shows high catalytic activity and selectivity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116395647-A
priorityDate 2018-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456979502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448373022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24884294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450395493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452744700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1390

Total number of triples: 44.